Reports of recovery from disease due to MGN-3
|
Chronic hepatitis,Chronic Hepatitis, Type B, and Liver Cancer（1）（2）,Chronic C type virus hepatitis（1）（2）（3）,Chronic C type virus hepatitis,stomach cancer,Cirrhosis,,Chronic hepatitis C, liver cancer（1）（2）,Chronic Hepatitis, Type C
Diabetes（1）,（2）,Diabetes (NIDDM),Diabetes (NIDDM), asthma
Breast Cancer（1）（2）（3）（4）（5）（6）（7）（8）（9）,Breast cancer (metastasis in the left neck lymph node) ,Breast cancer and metastases in the brain and lung
Hepatitis C（1）（2）｜Hepatitis C→liver cancer
Prostate cancer（1）（2）（3）（4）｜Colon Cancer（1）（2）（3）（4）,Colonic Cancer/Liver Metastasis,Colon polyp｜Pulmonary adenocarcinoma（1）（2）｜Atopic dermatitis（1）（2）（3）｜Articular rheumatism（1）（2）（3）
｜Endometriosis｜ Bladder cancer,Bladder Carcinoma｜Primary Malignant Lymphoma of the Left Breast ｜Articular Rheumatism｜Lung Cancer/Lib Metastasis,Lung cancer (terminal)｜Stomach Cancer,Stomach cancer (scirrhous)｜Liver cancer｜Metastatic Lung Cancer｜Pancreas Cancer, Gallbladder and Liver Metastasis｜Ovarian tumor｜Malignant liver cancer,Malignant lymphoma｜Infantile asthma｜Tonsillitis｜Pharynx cancer｜Oropharynx cancer｜Rectum cancer, bile duct cancer｜Pulmonary adenocarcinoma→metast asis to the pleura
|
|
|
|
| No. 45 Chronic C type virus hepatitis Facility/T Hospital
|
|
Patient's name/T. Y AGE/56 years SEX/Female AREA/Hyogo Prefecture
|
|
History of past diseases and treatments
In June 1997, screening of the patient revealed abnormal liver function. As a result of a complete
medical checkup, she was diagnosed with chronic C type virus hepatitis. The idea of treating her
with interferon was abandoned because the treatment proved ineffective. There was fear that the
disease would develop into cirrhosis because of high viral concentrations although she had no
symptoms of fatigue and jaundice. However, no special treatment was available. Besides treatment
with a restricted diet and Chinese medicine, she was given MGN-3 3 g daily. Three months after
start of treatment, her GOT and GPT levels were 39 and 29, respectively. Similar results were
obtained in an examination performed after 6 months. Follow-up care is necessary because viral
concentrations remain at high levels although they are decreasing.
Changes caused by ingestion of MGN-3
About 7 days after the start of MGN-3 therapy, fatigue began to disappear. The patient felt her
temperature rise and began to feel sleepy.
Evaluation of MGN-3
The action of MGN-3 to enhance immunopotency (activation of NK cells and production of
interferon) and protect the liver resulted in a decrease in viral concentrations and mitigation of liver
inflammation. Changes in subjective symptoms after ingestion of MGN-3 seem to be
manifestations of improvements in immunopotency.
|
|
| No. 46 Chronic C type virus hepatitis Facility/T Hospital
|
|
Patient's name/T. M AGE/60 years SEX/Male AREA/Shizuoka Prefecture
|
|
History of past diseases and treatments
The patient began to feel malaise and tire in his lower limbs in April 1996. These symptoms
persisted so he visited a hospital in September to undergo a complete medical checkup. Both the
GOT and GPT levels were about 400 and he was diagnosed with C type virus hepatitis. He
continued rest and dietary therapy and began receiving treatment with interferon in June 1997. At
this time point, the GOT and GPT levels were both between 180 and 190. In addition to interferon,
the patient took MGN-3 3 g daily. He remained at the hospital for the first 2 weeks of treatment
with interferon. During this period, no adverse effect was observed excepting a fever of 39?C or
more. He treated with interferon therapy for 6 months until late December by visiting the hospital 3
times weekly. No adverse effect or attacks of fever occurred during this course except for
occasional fits of malaise associated with injection with interferon. The GOT and GPT values were
within the normal limits. Examinations in January and May, 1998, revealed no viral reaction,
showing complete remission. He is now taking MGN-3 2 g daily to prevent recurrence.
Changes caused by ingestion of MGN-3
Interferon is thought to have strong adverse effects such as chills, anorexia and fever but the patient
did not have serious adverse effects.
Evaluation of MGN-3
The action of MGN-3 to enhance immunopotency and protect the liver increased the effectiveness
of interferon and resulted in complete recovery from C type virus hepatitis without major adverse
effects.
|
|
| No. 47 Articular rheumatism Facility/S Clinic
|
|
Patient's name/S. S AGE/25 years SEX/Female AREA/Kagoshima Prefecture
|
|
History of past diseases and treatments
The patient felt chills in her limbs in early July 1997. She attributed her chills to air conditioning
and took care not to overcool herself. Nevertheless, her limbs remained so cold as to become numb
and she never regained warmth. Meanwhile, her limbs began to swell and her joints suddenly
began to ache. In August, she visited this clinic for examination because she became unable to get
to sleep due to worsening pain. She was diagnosed with articular rheumatism. In addition to
analgesics, electrothermotherapy and herbal medicine, she was given MGN-3 in increasing doses
starting from 1 g daily for the first 1 week to 2 g to 3 g. She was put on a restricted diet that
contained lower calories and less animal proteins and more vegetables. The pain ameliorated in 1
week and she could use analgesics in lower doses. After 1 month, swellings in her limbs and face
disappeared and joint pain began to subside. After 3 months, she felt much less pain and was able
to sleep soundly. In March 1998, the pain almost disappeared and she recovered free movement of
her middle fingers, which were painful to bend.
Changes caused by ingestion of MGN-3
Three days after start of treatment with MGN-3, chills in upper and lower limbs began to improve
and she felt more warmth and less pain.
Evaluation of MGN-3
The action of MGN-3 to normalize immunity improved symptoms of articular rheumatism, which
is an autoimmune disease.
|
|
| No. 48 Diabetes (NIDDM), asthma Facility/I Clinic
|
|
Patient's name/K. N AGE/66 years SEX/Male AREA/Hyogo Prefecture
|
|
History of past diseases and treatments
In June 1993, the patient had to get up a number of times during the night for urination and had to
drink water frequently to satisfy thirst. He visited a hospital for examination and was diagnosed
with diabetes. The blood sugar level was 320 mg/dl. In September, he was hospitalized and began
to receive treatment. His blood sugar level did not decrease until March 1994 and he was
discharged because he developed hepatopathy, a possible complication, and recovery was delayed.
He continued treatment with insulin injections by hospital visit but fatigue did not disappear. He
also had occasional attacks of asthma and felt worse. At this time point, he began taking MGN-3 3
g daily. In May, 2 months after start of ingestion of MGN-3, the blood sugar level decreased to 110
mg/dl and insulin was no longer necessary. Symptoms of asthma also began to improve and he had
no attack of asthma from the autumn of 1994 to the spring of 1995. He is now feeling better and
working everyday. He still takes MGN-3 1 g daily to maintain health.
Changes caused by ingestion of MGN-3
Seven days after start of ingestion of MGN-3, malaise began to subside and the patient had a
comfortable awakening. Symptoms of asthma also ameliorated and the sense of incongruity in the
throat disappeared.
Evaluation of MGN-3
Treatment with MGN-3 that has the ability to improve sugar metabolism and normalize immunity
led to an improvement in constitution and hence improvements in diabetes and asthma.
|
|
No. 49 Breast cancer and metastases in the brain and lung
Facility/S Surgery
|
|
Patient's name/S. K AGE/63 years SEX/Female AREA/Toyama Prefecture
|
|
History of past diseases and treatments
On January 15, 1999, the patient presented with severe headache and numbness in the right limbs
at a nearby hospital and was diagnosed with common cold. Her general condition worsened and the
right half of her body was paralyzed in late January. She underwent examination at the brain
surgery department of another hospital and was found to have a brain tumor. Lung cancer and
metastases in lymph nodes were also discovered and the patient was told she had only 3 months to
live. She had undergone surgery for breast cancer in 1989 so these diseases were considered
recurrences or metastases. She refused the chemotherapy recommended by the hospital and was
admitted to S Surgery, which provided complementary medicine incorporating dietary,
psychological and immune therapies. She was given MGN-3 3 g daily as part of immunotherapy to
activate NK cells. The activity of NK cells increased to 52.6% 3 months after start of treatment and
all the tumors began shrinking. It is now 1 year and 6 months since she was told she had only 3
months to live and she continues treatment with dietary therapy, qigong and MGN-3 3 g daily and
is living a normal life.
Changes caused by ingestion of MGN-3
Ten days after start of treatment with MGN-3, the patient began to recover appetite and her
headache began to fade. She became able to sleep soundly, felt physical strength improve and felt
more optimistic about here life.
Evaluation of MGN-3
MGN-3 seems to be playing a leading role as an immunopotentiator in complementary medicine.
The high level of activity of NK cells indicates sufficient physical strength to resist cancer. The
patient is expected to maintain coexistence with cancer until she fully recovers.
|
|
|
No. 50 Oropharynx cancer Facility/S Surgery
|
| Patient's name/T. H AGE/64 years SEX/Male AREA/Chiba Prefecture
|
|
History of past diseases and treatments
In April 1998, the patient noticed a swelling in the lymph node on the right side of his neck. He
was having his teeth treated so he thought this treatment caused the swelling. Contrary to his
supposition, the swelling in the lymph node would not subside. He visited the National Cancer
Center in late May for a complete medical checkup and was diagnosed with oropharynx cancer.
The lesion grew to a size of 2.5 cm and the patient was classified as stage 3 cancer. The doctor in
charge recommended a treatment regimen that involved trying radiotherapy for 2 months and
performing operation as required. Because the patient feared adverse effects, he told the doctor that
he would choose alternative medicine and left the hospital. He began treating himself but the
disease advanced and he even had difficulty speaking. In March 1999, he visited S Surgery.
Complementary medicine including immunotherapy and thermotherapy was started in April. The
patient was given MGN-3 3 g daily to enhance immunity. After 2 weeks of hospitalization, the
tumor decreased to less than one third. He was discharged in late June and has been on
immunotherapy with vitamin B17 and MGN-3 by visiting the hospital once a week. The UK
activity increased from 7.4 at admission to 21.9 at discharge.
Changes caused by ingestion of MGN-3
Seven days after start of ingestion of MGN-3, the swelling in the mouth began to shrink and the
patient found speaking easier.
Evaluation of MGN-3
MGN-3 played a leading role as an immunopotentiator in the systematic
alternative/complementary medicine of S Surgery and showed immediate effectiveness. The tumor
is expected to disappear as the NK activity increases.
|
|
|
No. 51 Stomach cancer (scirrhous) Facility/S Surgery
|
|
Patient's name/K. W AGE/54 years SEX/Male AREA/Hyogo Prefecture
|
|
History of past diseases and treatments
In June 1998, the patient presented with upset stomach at a nearby hospital but no abnormality was
found. Because the patient continued to feel incongruity in his stomach, he visited a general
hospital in late December for reexamination. The result showed a scirrhous type stomach cancer
that is considered to have low success rates and he was told that he had only 6 months to live. In
February 1999, he was admitted to S Surgery and received alternative/complementary medicine
including psychological, dietary and immune therapies. He was given MGN-3 3 g daily as part of
immunotherapy. After hospitalization for 6 weeks after hospitalization, his appetite improved and
the activity of NK cells increased from 7.5 at admission to 27.7. He was discharged and is now
convalescing at home. He has not yet been rehabilitated but it is now 1 year since he was told he
had only 6 months to live.
Changes caused by ingestion of MGN-3
Stomach pain began to subside 2 weeks after start of treatment with MGN-3 and he felt physical
strength increasing.
Evaluation of MGN-3
A surprising fact is that most refractory scirrhous type stomach cancer has been arrested. The
immunopotentiating action of MGN-3 must have been responsible. The patient is expected to be in
coexistence with cancer as the NK cell activity increases.
|
|
|
No. 52 Chronic hepatitis C, liver cancer Facility/T Hospital
|
|
Patient's name/T. K AGE/58 years SEX/Male AREA/Shizuoka Prefecture
|
|
History of past diseases and treatments
The patient visited T Hospital in March 1998 for examination. The result showed that chronic
hepatitis C developed into cirrhosis and almost his entire liver was invaded by liver cancer. The
tumor marker AFP was 281,000 and the GOT and GPT levels were 51 and 79, respectively. In
addition to dietary therapy mainly consisting of semi-fasting and thermotherapy, the patient
received MGN-3 3 g daily to enhance immunopotency.
The test results are shown below.
Changes caused by ingestion of MGN-3
Two weeks after start of ingestion of MGN-3, the patient felt malaise begin to ameliorate and
became able to sleep soundly. Appetite also improved and he even began to feel fasting painful.
Evaluation of MGN-3
The immunopotenciating action of MGN-3 seems to have helped the patient recover from terminal
liver cancer. This impressive case exemplifies self-healing power and the power of MGN-3 that
assists it.
|
|
|
No. 53 Chronic hepatitis C, liver cancer Facility/O Clinic
|
|
Patient's name/T. K AGE/66 years SEX/Female AREA/Osaka Prefecture
|
|
History of past diseases and treatments
In 1990, the patient was diagnosed with hepatitis C but had no special subjective symptoms. In
July 1995, a health checkup revealed an abnormality in the liver and she had a complete medical
checkup at a general hospital, which revealed a 3-cm liver cancer lesion. The treatment regimen
involved infusing ethanol into the affected area. The patient was given MGN-3 3 g daily to reduce
the adverse effect of ethanol therapy and protect the liver. Ethanol therapy was repeated 7 times but
adverse effects such as fever, nausea and anorexia were mild. The AFP value also decreased from
602.5 to 7.2 so the patient was discharged on the last day of September. Although the GOT and
GPT values at discharge were 60 and 85, respectively, the examination of recurrence performed in
February 1996 showed that the area treated with ethanol was necrotized, the tumor disappeared
completely and the liver function normalized.
Changes caused by ingestion of MGN-3
As early as 3 days after treatment with MGN-3, the patient began to revive and regain appetite. She
felt she could endure ethanol therapy with increased physical strength and wished to recover
complete health.
Evaluation of MGN-3
Ethanol therapy is performed to solidify tumors with ethanol to prevent further growth but may
cause inflammations and pain in surrounding tissues. The immunopotentiating effect and
liver-protection effect of MGN-3 reduced the adverse effects of ethanol therapy and increased its
effectiveness.
|
|
|
No. 54 Breast cancer Facility/O Clinic
|
|
Patient's name/M. O AGE/55 years SEX/Female AREA/Fukuoka Prefecture
|
|
History of past diseases and treatments
In May 1997, a tumor was detected in her right breast and metastases in the lymph node were also
observed. She was immediately operated on. The operation was successful but a monthly follow-up
revealed a suspected metastasis in the upper portion of her left breast in July 1998. She was told
that she would take a complete medical checkup 3 weeks later and then a treatment regimen would
be established. The patient immediately began taking MGN-3 3 g daily to enhance immunity. After
3 weeks, workup by radiography and ultrasonography revealed no tumor. She visited the hospital
for the following 2 months and was told she had little chance of developing recurrent diseases.
Changes caused by ingestion of MGN-3
She was suffering headache and malaise after the first operation but began to feel headache and
fatigue disappear after treatment with MGN-3. She no longer felt incongruity in her breasts about 1
week after treatment.
Evaluation of MGN-3
Increased NK cell activity by MGN-3 enhanced overall self-healing ability and caused the tumor to
disappear. Breast cancer is considered to recur within 2 years so maintaining high postoperative
immunopotency is important. In these cases, MGN-3 seems to provide a potent weapon.
|
|
|
No. 55 Prostate cancer Facility/C Cancer Center
|
|
Patient's name/Y. M AGE/87 years SEX/Male AREA/Chiba Prefecture
|
|
History of past diseases and treatments
In the year following 1993 when the patient barely survived cardiac infarction, he had difficulty
urinating and visited C Cancer Center. He was diagnosed with prostate cancer the size of a quail
egg. He underwent 2 courses of treatment consisting of 1 week of chemotherapy with anticancer
drugs and 1 week of hormone therapy. He was given MGN-3 3 g daily during the course. As a
result, the tumor marker PSA decreased steadily and was within the normal limits after completion
of 2 courses. The tumor disappeared almost completely. There were few adverse effects and he lost
only 2 kg. Thereafter, he was given anticancer drugs and hormones regularly. In 1995, he felt
incongruity in his stomach and took a medical checkup. The result showed 2 cancer lesions at the
bottom of the stomach. He was immediately operated on and lost two-thirds of his stomach. At the
time, he received no anticancer drug considering his age and damage to the body. He began taking
MGN-3 when he was returned to a normal diet. As of May 2000, he shows no abnormal conditions
and the latest examination has revealed the disappearance of old lesions of cardiac infarction.
There have been no recurrent diseases of prostate cancer and stomach cancer for 6 and 5 years,
respectively.
Changes caused by ingestion of MGN-3
The patient took MGN-3 3 g daily along with anticancer drugs and did not lose appetite nor did he
experience any special adverse effect. In contrast, other patients in the same room undergoing
treatment with the same anticancer drugs lost appetite at the beginning of the second course.
Evaluation of MGN-3
The immunopotentiating effect of MGN-3 complemented conventional cancer treatment and led to
remission. This provides a valuable case. MGN-3 was shown to be an essential material for
improving QOL in cancer treatment.
|
|
|
No. 56 Articular rheumatism Facility/I Clinic
|
|
Patient's name/Y. S AGE/42 years SEX/Female AREA/Akita Prefecture
|
|
History of past diseases and treatments
In early April 1997, the patient noticed stiffness in her fingers when getting up. Later, her fingers
began to swell and redden from the base to the second joint and numbness and stiffness spread to
her wrists, elbows and shoulders. In October, she had pain and swellings in all joints including
heels and knees and had difficulty walking. She visited an orthopedist and was diagnosed with
rheumatism. Treatment with pain relievers and thermotherapy was ineffective and she was
hospitalized because of a high fever and the inability to walk due to generalized pain. The
symptoms somewhat improved after 6 weeks of hospitalization and she was discharged. In addition
to dietary therapy, she was given MGN-3 1 g daily for a week and the dose was increased to 3 g
daily thereafter. Stiffness was relieved from all joints 2 months after start of treatment with MGN-3
and the deformation of fingers and wrists improved after 3 months. Blood test showed that she was
negative for rheumatic reaction.
Changes caused by ingestion of MGN-3
The patient felt the swellings in her finger joints subside 7 days after start of treatment with
MGN-3 and felt her wrists, elbows and shoulders move smoothly, which she had previously felt
too much pain to move.
Evaluation of MGN-3
Rheumatism is an autoimmune diseases arising from abnormal functioning of immune cells. The
action of MGN-3 to normalize immune cells normalized the immune system in a short period and
improved rheumatism.
|
|
No. 57 Breast cancer (metastasis in the left neck lymph node)
Facility/T Clinic
|
|
Patient's name/M. M AGE/48 years SEX/Female AREA/Aichi Prefecture
|
|
History of past diseases and treatments
The patient noticed a swelling in her left neck lymph node. She visited a nearby hospital for a
complete medical checkup, which revealed a tumor in her left breast and diagnosed the swelling in
her left neck as a metastatic lesion. She was judged inoperable and put on chemotherapy with 3
anticancer drugs (Adriamycin, 5FU and cyclophosphamide). The left breast cancer involuted and the
lymphatic metastasis temporarily shrank. Because the metastasis resumed expanding and the tumor
market did not decrease, the patient received 4 sessions of chemotherapy.
In January 2000, weekly infusion with docetaxel wettable powder (Taxotere) was started (until July)
because there were increases in lymphatic metastasis and tumor maker values. On January 18, the
patient visited this clinic because she desired immunopotentiation therapy. On January 28, she began
to receive massive infusion with vitamin C (weekly) and Chinese medicine (Hochuekkito 7.5 g/day)
as well as MGN-3 3 g/day (1 g at a time) as immunopotentiation therapy. In June the same year,
shrinking of the lymph swelling was confirmed. Hormone therapy (progesterone preparation:
Hysron) replaced Taxotere in August. Since then, no recurrence or metastasis has been confirmed on
radiography, CT and ultrasonography although tumor markers are fluctuating.
Evaluation of MGN-3
After the patient began to take MGN-3 as part of immunopotentiation therapy in addition to
chemotherapy, NK cell activities increased and tumors decreased in size. Eight months after
treatment with MGN-3, NK cell activity increased more than 2-fold and this increase seems to have
contributed to the prevention of recurrence.
|
|
|
No. 58 Rectum cancer, bile duct cancer Facility/T Hospital
|
|
Patient's name/F. Y AGE/68 years SEX/Female AREA/Shizuoka Prefecture
|
|
History of past diseases and treatments
In October 1995, the patient was examined for occult blood in the stool and the result was positive. A
complete medical checkup revealed a cancer lesion that was so large as to occlude the rectum. No
metastasis was detected. She refused recommendations for chemotherapy and was trying
immunotherapy on her own. In November 1997, a metastatic lesion was confirmed in the liver and
she underwent excision of 15% of the liver and the gallbladder. The patient began to visit this
hospital in April 1998 and she was put on a restricted diet and given supplements. After 1 year of
dietary therapy, she felt much better and dietary therapy was discontinued at her own request. She
stopped visiting the hospital.
About 1 year after the discontinuation of treatment, the patient noticed that her urine was brown and
had generalized pain. She visited a nearby hospital for examination. The examination showed that her
total bilirubin was quite high and she developed obstructive jaundice due to metastatic bile duct
cancer, so she was immediately hospitalized. A stent was inserted first to expand the bile duct.
Another thicker stent was inserted after 1 month. Jaundice improved significantly but no operation or
radiotherapy was performed for cancer at her request.
She received an immunotherapeutic treatment of this hospital for her cancer. She was treated with a
combination of dietary therapy, an immunopotentiator MGN-3 and other health foods. MGN-3 was
given in a 7-day cycle of 4 successive days of dosing at 7 g/day and 3 days of discontinuity.
After about 2 months of treatment with immunotherapy, she no longer had high fevers and the cancer
rapidly decreased in size. About 6 months after start of immunotherapy, the cancer disappeared.
Evaluation of MGN-3
The bile duct cancer was progressive and the patient was recommended immediate surgery and
radiotherapy. She chose a treatment that would enhance self-healing potential in consideration of
QOL. MGN-3 was used to play a leading part in immunopotentiation and showed effectiveness in a
short period. The tumor was eliminated because overall spontaneous healing capacity increased.
|
|
|
Patient's name/H. Y AGE/45 years SEX/Male AREA/Tochigi Prefecture
|
|
History of past diseases and treatments
In 1999, the patient was found to have a GOT and GPT levels of more than 100 in a periodic health
examination. He had a complete medical checkup and was diagnosed with hepatitis C. He knew he
had lassitude. He was recommended but refused interferon therapy for fear of adverse effects.
Regular injection with strong Minophagen was the only alternative treatment.
After 6 months, the values of liver function parameters increased gradually. GOT increased to a
maximum of 215 and GPT to a maximum of 408, so he began to receive interferon therapy.
Before starting interferon therapy, he was given MGN-3 at 3 g/day and put on a diet that centered on
vegetables for 1 month to enhance immunopotency. After 1 month of MGN-3 treatment, GOT and
GPT were 20 and 28, respectively. Thus, interferon therapy was cancelled. He continues taking
MGN-3 3 g daily and the GOT and GPT levels are within the normal limits.
Evaluation of MGN-3
The initial treatment was ineffective partly because he was in the habit of smoking and drinking.
Because he gave up smoking and drinking and switched to a diet centering on vegetables, MGN-3
had immediate effect. The immunopotentiating effect (activation of NK cells, production of
interferon) and liver-protecting effect of MGN-3 resulted in a decrease in the viral population and
elimination of liver inflammation.
|
|
|
No. 60 Hepatitis C→liver cancer
|
|
AGE/49 years SEX/Male Method of ingesting MGN-3/Immunotherapy
|
|
History of past diseases and treatments
The patient was a carrier of hepatitis C virus and diagnosed with liver cancer. He had developed a
metastatic lesion in the peritoneum (tumor marker: 300,000) that was untreatable. He switched to a
diet centering on fresh vegetables and began to take MGN-3 3 g/day (1 g/day). Six months after start
of ingestion of MGN-3, the tumor maker dropped to 15 and no cancer cells were detected in the liver
or peritoneum.
Evaluation of MGN-3
Hepatitis C caused liver cancer and metastatic lesions were observed in the peritoneum. Although
the patient was considered untreatable, 6 months of strict diet and treatment with an
immunopotentiator MGN-3 resulted in elimination of cancer cells.
|
|
|
|
